|
DOSAGE
|
1 Tab PO qD, do not use more than 1 tab within 24 hours
|
|
GENERIC
|
Pseudoephedrine sulfate 240 mg/ Loratadine 10 mg
|
|
INDICATIONS
|
Loratadine; pseudoephedrine sulfate extended release tablets are indicated for the relief of symptoms of seasonal allergic rhinitis. Loratadine; pseudoephedrine sulfate extended release tablets should be administered when both the antihistaminic properties of loratadine and the nasal decongestant activity of pseudoephedrine are desired
|
|
MECHANISM OF ACTION
|
Nasal decongestant/Antihistamine
|
|
MICROBIOLOGY
|
Loratadine is a long-acting tricyclic antihistamine with selective peripheral histamine H1-receptor antagonistic activity.
|
|
CONTRAINDICATIONS & WARNINGS
|
Loratadine; pseudoephedrine sulfate extended release tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients.
|
|
This product, due to its pseudoephedrine component, is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (MAO) inhibitor therapy or within fourteen (14) days of stopping such treatment (see DRUG INTERACTIONS). It is also contraindicated in patients with severe hypertension, severe coronary artery disease, and in those who have shown hypersensitivity or idiosyncrasy to its components, to adrenergic agents, or to other drugs of similar chemical structures. Manifestations of patient idiosyncrasy to adrenergic agents include: insomnia, dizziness, weakness, tremor, or arrhythmias
|
|
PEDIATRIC USE
|
Safety and effectiveness in children below the age of 12 years have not been established.
|
|
PREGNANCY
|
Category B: Patients who are or may become pregnant should be told that this product should be used in pregnancy or during lactation only if the potential benefit justifies the potential risk to the fetus or nursing infant.
|
|
NOTE
|
Extended Release, aval in Non-Drowsy
|
